Establishment Labs Holdings Inc. $ESTA Shares Sold by GSA Capital Partners LLP

GSA Capital Partners LLP decreased its position in shares of Establishment Labs Holdings Inc. (NASDAQ:ESTA) by 59.9% in the fourth quarter, HoldingsChannel reports. The firm owned 15,917 shares of the company’s stock after selling 23,822 shares during the quarter. GSA Capital Partners LLP’s holdings in Establishment Labs were worth $1,160,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors and hedge funds have also recently modified their holdings of ESTA. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC lifted its holdings in shares of Establishment Labs by 20.1% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 57,215 shares of the company’s stock worth $2,335,000 after purchasing an additional 9,557 shares during the period. Geode Capital Management LLC lifted its holdings in shares of Establishment Labs by 1.2% during the second quarter. Geode Capital Management LLC now owns 25,917 shares of the company’s stock worth $1,105,000 after purchasing an additional 299 shares during the period. WINTON GROUP Ltd acquired a new position in Establishment Labs in the second quarter valued at approximately $651,000. Nebula Research & Development LLC lifted its holdings in Establishment Labs by 27.9% in the second quarter. Nebula Research & Development LLC now owns 16,214 shares of the company’s stock valued at $692,000 after acquiring an additional 3,538 shares during the period. Finally, Sei Investments Co. lifted its holdings in Establishment Labs by 13.3% in the second quarter. Sei Investments Co. now owns 48,428 shares of the company’s stock valued at $2,068,000 after acquiring an additional 5,668 shares during the period. Institutional investors and hedge funds own 72.91% of the company’s stock.

Analyst Ratings Changes

ESTA has been the subject of a number of analyst reports. Wall Street Zen downgraded Establishment Labs from a “buy” rating to a “hold” rating in a report on Saturday, March 28th. Needham & Company LLC boosted their price target on Establishment Labs from $84.00 to $86.00 and gave the company a “buy” rating in a report on Tuesday, February 24th. Mizuho boosted their price target on Establishment Labs from $90.00 to $100.00 and gave the company an “outperform” rating in a report on Wednesday, February 25th. Citigroup reissued a “neutral” rating on shares of Establishment Labs in a report on Wednesday, May 6th. Finally, Weiss Ratings reissued a “sell (e+)” rating on shares of Establishment Labs in a report on Friday, March 27th. Six research analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus target price of $87.14.

Insider Activity at Establishment Labs

In other news, Director Quiros Juan Jose Chacon sold 105,000 shares of the business’s stock in a transaction that occurred on Wednesday, May 6th. The stock was sold at an average price of $75.42, for a total value of $7,919,100.00. Following the completion of the sale, the director directly owned 927,504 shares in the company, valued at $69,952,351.68. The trade was a 10.17% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Insiders sold 330,000 shares of company stock valued at $22,854,538 in the last three months. 9.99% of the stock is owned by insiders.

Establishment Labs Trading Up 1.7%

Shares of NASDAQ:ESTA opened at $71.23 on Friday. The company has a market capitalization of $2.10 billion, a PE ratio of -47.81 and a beta of 1.12. Establishment Labs Holdings Inc. has a 12-month low of $33.35 and a 12-month high of $83.31. The business has a 50 day moving average of $64.47 and a two-hundred day moving average of $67.91. The company has a current ratio of 2.96, a quick ratio of 1.91 and a debt-to-equity ratio of 16.82.

Establishment Labs (NASDAQ:ESTA) last posted its quarterly earnings data on Thursday, May 7th. The company reported ($0.45) EPS for the quarter, missing analysts’ consensus estimates of ($0.35) by ($0.10). The business had revenue of $59.88 million during the quarter, compared to analysts’ expectations of $57.40 million. Establishment Labs had a negative net margin of 19.05% and a negative return on equity of 218.77%. The firm’s quarterly revenue was up 44.7% compared to the same quarter last year. During the same quarter last year, the firm earned ($0.70) earnings per share. As a group, analysts forecast that Establishment Labs Holdings Inc. will post -1.07 EPS for the current year.

About Establishment Labs

Establishment Labs Holdings Inc is a global medical technology company specializing in the design, development and manufacture of silicone gel breast implants for aesthetic and reconstructive surgery. The company’s proprietary portfolio is built around patient-focused safety, customization and innovation, offering solutions intended to enhance surgical outcomes and support clinical traceability.

The company’s flagship products fall under the Motiva® brand, which includes a range of ergonomic and round breast implants featuring SilkSurface® texturing and an embedded Q Inside® Safety microtransponder for unique implant identification.